Genomic Vision S.A. | Cash Flow
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,069.00
2,156.00
4,338.00
8,613.00
9,071.00
6,898
Depreciation, Depletion & Amortization
202.00
214.00
352.00
490.00
689.00
538
Other Funds
4.00
-
-
-
-
613
Funds from Operations
695.00
1,935.00
4,645.00
7,847.00
7,662.00
5,747
Changes in Working Capital
938.00
1,836.00
890.00
286.00
225.00
153
Net Operating Cash Flow
243.00
3,771.00
5,535.00
8,133.00
7,887.00
5,594
Capital Expenditures
110.00
441.00
1,540.00
563.00
317.00
Sale of Fixed Assets & Businesses
-
15.00
-
4.00
-
Purchase/Sale of Investments
6.00
197.00
33.00
2.00
84.00
Net Investing Cash Flow
116.00
623.00
1,573.00
561.00
401.00
Issuance/Reduction of Debt, Net
101.00
30.00
32.00
20.00
929.00
Net Financing Cash Flow
1,945.00
23,932.00
63.00
13.00
3,429.00
Net Change in Cash
2,072.00
19,538.00
7,171.00
8,707.00
4,858.00
Free Cash Flow
243.00
4,046.00
7,022.00
8,675.00
8,192.00
Change in Capital Stock
2,042.00
23,962.00
31.00
7.00
2,500.00
Miscellaneous Funds
-
-
-
-
1.00
About Genomic Vision
View Profile
